Association of JC Virus T-Antigen Expression With the Methylator Phenotype in Sporadic Colorectal Cancers

Gastroenterology

Volumn 130, Issue 7, 2006, Pages 1950-1961

  Goel, Ajay ^a   Li, Mei Shu ^a   Nagasaka, Takeshi ^a   Shin, Sung Kwan ^a   Fuerst, Florentine ^a   Ricciardiello, Luigi ^a   Wasserman, Linda ^b   Boland, C Richard ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS T ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; EPIGENETICS; GENE SEQUENCE; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JC VIRUS; METHYLATION; MICROSATELLITE INSTABILITY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 33744516138     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.02.061     Document Type: Article

References (60)

1. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51 (1991) 3075-3079
2. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
3. Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Pylkkanen L., Mecklin J.P., Jarvinen H., Powell S.M., Jen J., and Hamilton S.R. Clues to the pathogenesis of familial colorectal cancer. Science 260 (1993) 812-816
4. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., and Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993) 558-561
5. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., and Lindblom A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994) 258-261
6. Papadopoulos N., Nicolaides N.C., Wei Y.F., Ruben S.M., Carter K.C., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser C.M., and Adams M.D. Mutation of a mutL homolog in hereditary colon cancer. Science 263 (1994) 1625-1629
7. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., Igari T., Koike M., Chiba M., and Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17 (1997) 271-272
8. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., and Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
9. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., and Issa J.P. Alterations in DNA methylation. a fundamental aspect of neoplasia. Adv Cancer Res 72 (1998) 141-196
10. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat Genet 21 (1999) 163-167
11. Goel A., Arnold C.N., Niedzwiecki D., Chang D.K., Ricciardiello L., Carethers J.M., Dowell J.M., Wasserman L., Compton C., Mayer R.J., Bertagnolli M.M., and Boland C.R. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 63 (2003) 1608-1614
12. Jones P.A. DNA methylation errors and cancer. Cancer Res 56 (1996) 2463-2467
13. Dell G., and Gaston K. Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci 58 (2001) 1923-1942
14. Monto A., and Wright T.L. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 28 (2001) 441-449
15. Knecht H., Berger C., Rothenberger S., Odermatt B.F., and Brousset P. The role of Epstein-Barr virus in neoplastic transformation. Oncology 60 (2001) 289-302
16. Rizzo P., Bocchetta M., Powers A., Foddis R., Stekala E., Pass H.I., and Carbone M. SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol 11 (2001) 63-71
17. Butel J.S. Viral carcinogenesis. revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21 (2000) 405-426
18. Dorries K. New aspects in the pathogenesis of polyomavirus-induced disease. Adv Virus Res 48 (1997) 205-261
19. Major E.O., Amemiya K., Tornatore C.S., Houff S.A., and Berger J.R. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5 (1992) 49-73
20. Padgett B.L., Walker D.L., ZuRhein G.M., Eckroade R.J., and Dessel B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1 (1971) 1257-1260
21. Walker D.L., Padgett B.L., ZuRhein G.M., Albert A.E., and Marsh R.F. Human papovavirus (JC). induction of brain tumors in hamsters. Science 181 (1973) 674-676
22. Laghi L., Randolph A.E., Chauhan D.P., Marra G., Major E.O., Neel J.V., and Boland C.R. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 96 (1999) 7484-7489
23. Ricciardiello L., Chang D.K., Laghi L., Goel A., Chang C.L., and Boland C.R. Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 75 (2001) 1996-2001
24. Ricciardiello L., Laghi L., Ramamirtham P., Chang C.L., Chang D.K., Randolph A.E., and Boland C.R. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 119 (2000) 1228-1235
25. Enam S., Del Valle L., Lara C., Gan D.D., Ortiz-Hidalgo C., Palazzo J.P., and Khalili K. Association of human polyomavirus JCV with colon cancer. evidence for interaction of viral T-antigen and β-catenin. Cancer Res 62 (2002) 7093-7101
26. Duran A., and Nerurkar V. Association of polyomavirus JC with colon cancer. Ethn Dis 15 (2005) S4-S9
27. Theodoropoulos G., Panoussopoulos D., Papaconstantinou I., Gazouli M., Perdiki M., Bramis J., and Lazaris A.C. Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum 48 (2005) 86-91
28. Casini B., Borgese L., Del Nonno F., Galati G., Izzo L., Caputo M., Perrone D.R., Castelli M., Risuleo G., and Visca P. Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. Anticancer Res 25 (2005) 1079-1085
29. Ludlow J.W. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J 7 (1993) 866-871
30. Cotsiki M., Lock R.L., Cheng Y., Williams G.L., Zhao J., Perera D., Freire R., Entwistle A., Golemis E.A., Roberts T.M., Jat P.S., and Gjoerup O.V. Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc Natl Acad Sci U S A 101 (2004) 947-952
31. Ricciardiello L., Baglioni M., Giovannini C., Pariali M., Cenacchi G., Ripalti A., Landini M.P., Sawa H., Nagashima K., Frisque R.J., Goel A., Boland C.R., Tognon M., Roda E., and Bazzoli F. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 63 (2003) 7256-7262
32. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Ranzani G.N., and Srivastava S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition. development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
33. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR. a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 (1996) 9821-9826
34. Goel A., Arnold C.N., Niedzwiecki D., Carethers J.M., Dowell J.M., Wasserman L., Compton C., Mayer R.J., Bertagnolli M.M., and Boland C.R. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 64 (2004) 3014-3021
35. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
36. Young J., Simms L.A., Biden K.G., Wynter C., Whitehall V., Karamatic R., George J., Goldblatt J., Walpole I., Robin S.A., Borten M.M., Stitz R., Searle J., McKeone D., Fraser L., Purdie D.R., Podger K., Price R., Buttenshaw R., Walsh M.D., Barker M., Leggett B.A., and Jass J.R. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings. parallel pathways of tumorigenesis. Am J Pathol 159 (2001) 2107-2116
37. Vogelstein B., Fearon E.R., Kern S.E., Hamilton S.R., Preisinger A.C., Nakamura Y., and White R. Allelotype of colorectal carcinomas. Science 244 (1989) 207-211
38. Kern S.E., Fearon E.R., Tersmette K.W., Enterline J.P., Leppert M., Nakamura Y., White R., Vogelstein B., and Hamilton S.R. Clinical and pathological associations with allelic loss in colorectal carcinoma. (corrected). JAMA 261 (1989) 3099-3103
39. Duval A., and Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers. toward a new concept of target genes for instability. Cancer Res 62 (2002) 2447-2454
40. Samowitz W.S., Albertsen H., Herrick J., Levin T.R., Sweeney C., Murtaugh M.A., Wolff R.K., and Slattery M.L. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
41. Issa J.P. CpG island methylator phenotype in cancer. Nat Rev Cancer 4 (2004) 988-993
42. Lazutka J.R., Neel J.V., Major E.O., Dedonyte V., Mierauskine J., Slapsyte G., and Kesminiene A. High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytes. Cancer Lett 109 (1996) 177-183
43. Neel J.V., Major E.O., Awa A.A., Glover T., Burgess A., Traub R., Curfman B., and Satoh C. Hypothesis. "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncopenesis. Proc Natl Acad Sci U S A 93 (1996) 2690-2695
44. Bestor T.H. The host defence function of genomic methylation patterns. Novartis Found Symp 214 (1998) 187-195
45. Doerfler W. DNA methylation. eukaryotic defense against the transcription of foreign genes?. Microb Pathog 12 (1992) 1-8
46. Soejima K., Fang W., and Rollins B.J. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene 22 (2003) 4723-4733
47. Kang G.H., Lee S., Kim W.H., Lee H.W., Kim J.C., Rhyu M.G., and Ro J.Y. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160 (2002) 787-794
48. Yang B., Guo M., Herman J.G., and Clark D.P. Aberrant promoter methylation profiles of tumor-suppressor genes in hepatocellular carcinoma. Am J Pathol 163 (2003) 1101-1107
49. Shivapurkar N., Takahashi T., Reddy J., Zheng Y., Stastny V., Collins R., Toyooka S., Suzuki M., Parikh G., Asplund S., Kroft S.H., Timmons C., McKenna R.W., Feng Z., and Gazdar A.F. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res 64 (2004) 3757-3760
50. Suzuki M., Toyooka S., Shivapurkar N., Shigematsu H., Miyajima K., Takahashi T., Stastny V., Zern A.L., Fujisawa T., Pass H.I., Carbone M., and Gazdar A.F. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 24 (2005) 1302-1308
51. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., and Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
52. Nagasaka T., Sasamoto H., Notohara K., Cullings H.M., Takeda M., Kimura K., Kambara T., MacPhee D.G., Young J., Leggett B.A., Jass J.R., Tanaka N., and Matsubara N. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22 (2004) 4584-4594
53. Lee S., Lee H.J., Kim J.H., Lee H.S., Jang J.J., and Kang G.H. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163 (2003) 1371-1378
54. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowitz S., Willson J.K., Hamilton S.R., Kinzler K.W., Kane M.F., Kolodner R.D., Vogelstein B., Kunkel T.A., and Baylin S.B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95 (1998) 6870-6875
55. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., and Herman J.G. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60 (2000) 129-133
56. Dong S.M., Kim H.S., Rha S.H., and Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7 (2001) 1982-1986
57. Goel A., Arnold C.N., Tassone P., Chang D.K., Niedzwiecki D., Dowell J.M., Wasserman L., Compton C., Mayer R.J., Bertagnolli M.M., and Boland C.R. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 112 (2004) 754-759
58. Virmani A.K., Rathi A., Zochbauer-Muller S., Sacchi N., Fukuyama Y., Bryant D., Maitra A., Heda S., Fong K.M., Thunnissen F., Minna J.D., and Gazdar A.F. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas. J Natl Cancer Inst 92 (2000) 1303-1307
59. Hoon D.S., Spugnardi M., Kuo C., Huang S.K., Morton D.L., and Taback B. Profiling epigenetic inactivation of tumor-suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 23 (2004) 4014-4022
60. Arnold C.N., Goel A., Niedzwiecki D., Dowell J.M., Wasserman L., Compton C., Mayer R.J., Bertagnolli M.M., and Boland C.R. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biol Ther 3 (2004) 960-964